Your browser is no longer supported. Please, upgrade your browser.
ZYXI Zynex, Inc. daily Stock Chart
Zynex, Inc.
Index- P/E25.22 EPS (ttm)0.30 Insider Own54.89% Shs Outstand32.59M Perf Week2.90%
Market Cap242.47M Forward P/E22.55 EPS next Y0.33 Insider Trans- Shs Float15.17M Perf Month40.38%
Income10.00M PEG- EPS next Q0.06 Inst Own1.00% Short Float0.27% Perf Quarter50.30%
Sales34.20M P/S7.09 EPS this Y26.50% Inst Trans- Short Ratio0.47 Perf Half Y138.81%
Book/sh0.36 P/B20.67 EPS next Y26.92% ROA63.60% Target Price8.38 Perf Year150.22%
Cash/sh0.29 P/C25.79 EPS next 5Y- ROE105.20% 52W Range2.34 - 8.00 Perf YTD153.06%
Dividend- P/FCF35.14 EPS past 5Y26.20% ROI103.30% 52W High-6.00% Beta0.99
Dividend %- Quick Ratio3.00 Sales past 5Y8.00% Gross Margin80.80% 52W Low221.83% ATR0.40
Employees182 Current Ratio3.20 Sales Q/Q33.30% Oper. Margin31.10% RSI (14)74.39 Volatility7.77% 5.65%
OptionableNo Debt/Eq0.00 EPS Q/Q24.80% Profit Margin29.20% Rel Volume1.16 Prev Close7.44
ShortableYes LT Debt/Eq0.00 Earnings- Payout0.00% Avg Volume86.16K Price7.52
Recom1.50 SMA2014.77% SMA5037.37% SMA20095.03% Volume99,805 Change1.08%
May-20-19 08:51AM  Are Investors Undervaluing Zynex, Inc. (NASDAQ:ZYXI) By 28%? Simply Wall St.
May-02-19 06:56PM  Edited Transcript of ZYXI earnings conference call or presentation 30-Apr-19 8:15pm GMT Thomson Reuters StreetEvents +11.52%
Apr-30-19 04:04PM  Zynex Announces 2019 First Quarter Earnings PR Newswire
02:15PM  Zynex, Inc. to Host Earnings Call ACCESSWIRE
08:43AM  How Do Analysts See Zynex, Inc. (NASDAQ:ZYXI) Performing In The Year Ahead? Simply Wall St.
Apr-25-19 04:02PM  Zynex Schedules 2019 First Quarter Earnings PR Newswire
Apr-07-19 09:45AM  Zynex, Inc. (NASDAQ:ZYXI): How Much Money Comes Back To Investors? Simply Wall St.
Mar-26-19 09:00AM  Zynex to Present at the Spring Investor Summit on April 2nd in New York City at the Essex House ACCESSWIRE
Mar-19-19 09:12AM  Zynex Reactivates Medicare Provider Number in Effort to Accelerate Growth PR Newswire
Mar-12-19 09:14AM  Zynex Expands Corporate Headquarters to Accommodate Growth PR Newswire
08:45AM  LD Micro Virtual Conference Is Live, March 12th and 13th ACCESSWIRE
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also distributes electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct and independent sales representatives primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.